Following a limited submission
AWMSG advice |
|||
| Status: Recommended | |||
Cefuroxime (Aprokam®) is recommended as an option for use within NHS Wales for the antibiotic prophylaxis of postoperative endophthalmitis after cataract surgery. |
|||
|
|||
Medicine details |
|||
| Medicine name | cefuroxime (Aprokam®) | ||
| Formulation | 50 mg powder for solution for injection | ||
| Reference number | 2224 | ||
| Indication | Postoperative endophthalmitis after cataract surgery |
||
| Company | Thea Pharamaceuticals Ltd. | ||
| BNF chapter | Eye | ||
| Submission type | Limited | ||
| Status | Recommended | ||
| Advice number | 1417 | ||
| NMG meeting date | 07/06/2017 | ||
| AWMSG meeting date | 19/07/2017 | ||
| Date of issue | 07/08/2017 | ||
| Date of last review | August 2020 | ||